Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Leerink Partners Analyst Initiates Coverage on Labcorp with Outperform Rating and 260 Price Target

Elaine Mendonca by Elaine Mendonca
February 26, 2024
in Breaking News
0
Finances
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

On February 26, 2024, Michael Cherny, an analyst at Leerink Partners, began covering Laboratory Corp (NYSE:LH) with an optimistic outlook, giving it an Outperform rating and setting a price target of $260. Labcorp is a key player in the clinical and laboratory sector, providing a wide range of tests and specialized services. They handle claims for insured patients with Medicare, Medicaid, and various insurance providers and managed care plans. It’s important to regularly check and update insurance details to guarantee adequate coverage.

LH Stock Price Drops Slightly on February 26, 2024 – Is It a Temporary Fluctuation or Signaling a Trend?

On February 26, 2024, LH stock experienced a slight drop in its price performance. The stock opened at $218.91, which was $0.25 lower than its previous close. Throughout the day, the price of LH shares decreased by $0.63, resulting in a 0.29% drop overall.

Investors should keep an eye on LH stock to see if this drop in price is just a temporary fluctuation or if it signals a more significant trend. It’s important to consider the overall market conditions and any relevant news or events that may be impacting the stock’s performance.

Lufthansa Group (LH) Stock Performance: Financial Results for February 26, 2024

On February 26, 2024, Lufthansa Group (LH) stock performance was closely watched by investors and analysts as the company released its financial results for the past year and the fourth quarter. According to data from CNN Money, LH reported a total revenue of $12.16 billion for the past year, which represented a decrease of 18.25% compared to the previous year. The total revenue for the fourth quarter was $3.03 billion, which was flat compared to the previous quarter.

In terms of net income, LH reported a net income of $418.00 million for the past year, which was a decrease of 67.32% compared to the previous year. However, the net income for the fourth quarter showed some improvement as it was reported at -$167.10 million, which was an increase of 0.0% compared to the previous quarter.

Earnings per share (EPS) for LH also saw a decline over the past year. The EPS for the past year was reported at $4.77, which was a decrease of 65.84% compared to the previous year. The EPS for the fourth quarter was -$1.95, which showed no change compared to the previous quarter.

Overall, the financial results for LH on February 26, 2024, showed a mixed performance. Investors and analysts will be closely monitoring the company’s performance in the coming quarters to see if LH can sustain its growth and profitability.

Tags: LH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Stock Charts (2)

Calculating AES Stock Dividend Requirements for Monthly Income

Aerospace and Defense Markets and money

Intuitive Machines Lunar Landing Setback Challenges and Uncertainties Ahead

Real Estate Investment Markets and money

PulteGroup A Decade of Impressive Performance in the Housing Sector

Recommended

Rocket Companies Stock

Rocket Companies Stock Surges on Fed Policy Speculation

7 months ago
Biopharmaceutical Markets and money (1)

Groundbreaking Preclinical Data on TN301 A Potential Breakthrough in Treating HFpEF

2 years ago
Airbnb Stock

Airbnb Faces Dual Challenges as Insiders Sell and Fee Structure Shifts

7 months ago
MSCI World ETF Stock

MSCI World ETF Reaches New Heights Amid Tech Sector Surge

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

Palo Alto Networks Finalizes Debt Terms Following CyberArk Acquisition

Kuya Silver Shares Show Signs of Technical Recovery

Trending

Oracle Stock
AI & Quantum Computing

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

by Jackson Burston
March 25, 2026
0

While much of the market's attention remains fixed on the developers of large AI models, Oracle has...

Alphabet Stock

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

March 25, 2026
Ocugen Stock

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Coinbase Stock

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Unitedhealth Stock

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Oracle’s Backlog Soars on Cloud and AI Contract Momentum
  • Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion
  • Ocugen Shares Tumble Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com